HomeCompareAWH vs KMB

AWH vs KMB: Dividend Comparison 2026

AWH yields 2439.02% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AWH wins by $63854957655.65M in total portfolio value
10 years
AWH
AWH
● Live price
2439.02%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63854957655.69M
Annual income
$59,089,222,446,113,760.00
Full AWH calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — AWH vs KMB

📍 AWH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAWHKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AWH + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AWH pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AWH
Annual income on $10K today (after 15% tax)
$207,317.07/yr
After 10yr DRIP, annual income (after tax)
$50,225,839,079,196,696.00/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, AWH beats the other by $50,225,839,079,192,264.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AWH + KMB for your $10,000?

AWH: 50%KMB: 50%
100% KMB50/50100% AWH
Portfolio after 10yr
$31927478827.87M
Annual income
$29,544,611,223,059,484.00/yr
Blended yield
92.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

AWH
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
Price Target
$3.30
+3924.4% upside vs current
Range: $3.30 — $3.30
Altman Z
-107.5
Piotroski
2/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AWH buys
0
KMB buys
0
No recent congressional trades found for AWH or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAWHKMB
Forward yield2439.02%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$63854957655.69M$45.9K
Annual income after 10y$59,089,222,446,113,760.00$5,211.33
Total dividends collected$63521423927.75M$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$3.30$123.00

Year-by-year: AWH vs KMB ($10,000, DRIP)

YearAWH PortfolioAWH Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$254,602$243,902.44$11,314$613.68+$243.3KAWH
2$6,075,991$5,803,565.97$12,865$759.19+$6.06MAWH
3$135,940,468$129,439,158.13$14,709$943.96+$135.93MAWH
4$2,851,990,824$2,706,534,523.24$16,919$1,180.17+$2851.97MAWH
5$56,119,194,681$53,067,564,499.36$19,588$1,484.33+$56119.18MAWH
6$1,035,955,104,440$975,907,566,131.16$22,838$1,879.06+$1035955.08MAWH
7$17,945,072,646,301$16,836,600,684,550.52$26,832$2,395.60+$17945072.62MAWH
8$291,769,260,867,746$272,568,033,136,203.20$31,788$3,077.63+$291769260.84MAWH
9$4,453,958,139,792,869$4,141,765,030,664,381.00$38,000$3,986.82+$4453958139.75MAWH
10$63,854,957,655,692,136$59,089,222,446,113,760.00$45,872$5,211.33+$63854957655.65MAWH

AWH vs KMB: Complete Analysis 2026

AWHStock

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.

Full AWH Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this AWH vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AWH vs SCHDAWH vs JEPIAWH vs OAWH vs KOAWH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.